PA Consulting Group - the leading international management, systems and technology consultancy - will give insight to devising cost benefit analysis/future strategy, and to outsourcing performance management at Pharma SRM 2008, 27- 29 October 2008, Frankfurt.
Through two contributions to the program, a PA team of healthcare and manufacturing consultants will overlay deep insight to pharmaceutical procurement processes with examples of other industries’ sourcing ‘best practice’ to provide practical and valuable guidance on effective relationship management:
Tuesday 28 October at 13.10hrs
Devising a Cost Benefit Analysis of your SRM Programme, and Planning Future Strategies
Wednesday, 29 October
Outsourcing Performance Management - a post-conference, interactive workshop, in four sessions:
Fundamentals of outsourcing performance management
A collaborative approach to robust, performance based contracts
Measuring your outsourcing partners’ performance
Management and governance processes to ensure robust performance.
Chris Nuttall, a Member of PA’s Management Group with extensive pharma outsourcing experience in the US and UK comments:
‘PA’s sessions will be of particular benefit to business and procurement leaders in global life sciences organizations that are looking to drive business value through their sourcing and outsourcing strategies.’
Kevin Deane - workshop leader - is a Managing Consultant in PA’s Global Technology Group. His 25-year cross-industry career has focussed on R&D improvement and technology developments. Kevin has worked with many companies over the past 12 years improving R&D performance, including implementation of lean/agile methods, improving innovation effectiveness, implementing new sourcing models and developing breakthrough technologies and products.
Pharma SRM 2008 – Supplier Relationship Management in the Pharma Industry, 27 – 29 October, Frankfurt Marriott Hotel, Frankfurt, Germany. www.pharmasrm.com
Notes to editors
PA's healthcare capability spans technology development and delivery, and consulting services for life science companies, through to supporting the health sector on healthcare delivery and reform.
Global pharmaceutical and biotechnology consultancy services
PA supports drug discovery, development, manufacturing and commercialisation activities from strategy to implementation. Core services are: strategies for commercial excellence; improving R&D effectiveness; and enhancing supply chain performance.
Delivering innovative healthcare technology
PA invests heavily in its UK and US technology centres. Over 200 scientists and engineers from the life sciences industry, design, develop and deliver pharmaceutical products, drug-delivery devices, process automation machinery, and novel scientific instruments
Award-winning health sector consulting.
PA's expertise addresses the most critical business issues that affect payers, providers and managed care companies. We advise on and support the implementation of new health policy, improving performance against targets, providing IT solutions to enable delivery of change, managing delivery of change, supporting organisational development, and modelling and analysing data to provide healthcare management information.
Investing in IP
Our willingness to invest in IP has led to unique propositions in improved patient safety through product authentication at the point of dispensing™, addressing the growing concern over counterfeiting. We have also developed patented technologies to radically improve discovery planning and execution.